These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
950 related articles for article (PubMed ID: 7553622)
21. Deletion and mutation analyses of the P16/MTS-1 tumor suppressor gene in human ductal pancreatic cancer reveals a higher frequency of abnormalities in tumor-derived cell lines than in primary ductal adenocarcinomas. Huang L; Goodrow TL; Zhang SY; Klein-Szanto AJ; Chang H; Ruggeri BA Cancer Res; 1996 Mar; 56(5):1137-41. PubMed ID: 8640773 [TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor genes in the 9p21 gene cluster are selective targets of inactivation in neuroendocrine gastroenteropancreatic tumors. Lubomierski N; Kersting M; Bert T; Muench K; Wulbrand U; Schuermann M; Bartsch D; Simon B Cancer Res; 2001 Aug; 61(15):5905-10. PubMed ID: 11479232 [TBL] [Abstract][Full Text] [Related]
23. Frequent deletion and 5' CpG island methylation of the p16 gene in primary malignant lymphoma of the brain. Zhang SJ; Endo S; Ichikawa T; Washiyama K; Kumanishi T Cancer Res; 1998 Mar; 58(6):1231-7. PubMed ID: 9515810 [TBL] [Abstract][Full Text] [Related]
24. Inactivation of the cyclin-dependent kinase inhibitor p15INK4b by deletion and de novo methylation with independence of p16INK4a alterations in murine primary T-cell lymphomas. Malumbres M; Pérez de Castro I; Santos J; Meléndez B; Mangues R; Serrano M; Pellicer A; Fernández-Piqueras J Oncogene; 1997 Mar; 14(11):1361-70. PubMed ID: 9178896 [TBL] [Abstract][Full Text] [Related]
25. Frequent and selective methylation of p15 and deletion of both p15 and p16 in T-cell acute lymphoblastic leukemia. Batova A; Diccianni MB; Yu JC; Nobori T; Link MP; Pullen J; Yu AL Cancer Res; 1997 Mar; 57(5):832-6. PubMed ID: 9041181 [TBL] [Abstract][Full Text] [Related]
26. CDKN2 (MTS1) tumor suppressor gene mutations in human tumor cell lines. Liu Q; Neuhausen S; McClure M; Frye C; Weaver-Feldhaus J; Gruis NA; Eddington K; Allalunis-Turner MJ; Skolnick MH; Fujimura FK Oncogene; 1995 Mar; 10(6):1061-7. PubMed ID: 7700630 [TBL] [Abstract][Full Text] [Related]
27. The gene for a novel transmembrane protein containing epidermal growth factor and follistatin domains is frequently hypermethylated in human tumor cells. Liang G; Robertson KD; Talmadge C; Sumegi J; Jones PA Cancer Res; 2000 Sep; 60(17):4907-12. PubMed ID: 10987305 [TBL] [Abstract][Full Text] [Related]
28. High incidence of allelic loss on chromosome 5 and inactivation of p15INK4B and p16INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Tanaka T; Iwasa Y; Kondo S; Hiai H; Toyokuni S Oncogene; 1999 Jun; 18(25):3793-7. PubMed ID: 10391689 [TBL] [Abstract][Full Text] [Related]
29. Expression of p15 and p15.5 products in neuroendocrine lung tumours: relationship with p15(INK4b) methylation status. Chaussade L; Eymin B; Brambilla E; Gazzeri S Oncogene; 2001 Oct; 20(45):6587-96. PubMed ID: 11641784 [TBL] [Abstract][Full Text] [Related]
30. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Reed AL; Califano J; Cairns P; Westra WH; Jones RM; Koch W; Ahrendt S; Eby Y; Sewell D; Nawroz H; Bartek J; Sidransky D Cancer Res; 1996 Aug; 56(16):3630-3. PubMed ID: 8705996 [TBL] [Abstract][Full Text] [Related]
31. Alterations of retinoblastoma, p53, p16(CDKN2), and p15 genes in human astrocytomas. Tsuzuki T; Tsunoda S; Sakaki T; Konishi N; Hiasa Y; Nakamura M Cancer; 1996 Jul; 78(2):287-93. PubMed ID: 8674005 [TBL] [Abstract][Full Text] [Related]
32. Silencing of p16/CDKN2 expression in human gliomas by methylation and chromatin condensation. Costello JF; Berger MS; Huang HS; Cavenee WK Cancer Res; 1996 May; 56(10):2405-10. PubMed ID: 8625319 [TBL] [Abstract][Full Text] [Related]
33. Association of rat p15INK4B/p16INK4 deletions with monosomy 5 in kidney epithelial cell lines but not primary renal tumors. Knapek DF; Serrano M; Beach D; Trono D; Walker CL Cancer Res; 1995 Apr; 55(8):1607-12. PubMed ID: 7712460 [TBL] [Abstract][Full Text] [Related]
34. Mechanisms of inactivation of p14ARF, p15INK4b, and p16INK4a genes in human esophageal squamous cell carcinoma. Xing EP; Nie Y; Song Y; Yang GY; Cai YC; Wang LD; Yang CS Clin Cancer Res; 1999 Oct; 5(10):2704-13. PubMed ID: 10537333 [TBL] [Abstract][Full Text] [Related]
35. Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas. Schutte M; Hruban RH; Geradts J; Maynard R; Hilgers W; Rabindran SK; Moskaluk CA; Hahn SA; Schwarte-Waldhoff I; Schmiegel W; Baylin SB; Kern SE; Herman JG Cancer Res; 1997 Aug; 57(15):3126-30. PubMed ID: 9242437 [TBL] [Abstract][Full Text] [Related]
36. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines. Fujishita T; Mizushima Y; Kashii T; Kobayashi M Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367 [TBL] [Abstract][Full Text] [Related]
37. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Geradts J; Kratzke RA; Niehans GA; Lincoln CE Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382 [TBL] [Abstract][Full Text] [Related]
38. Methylation of the multi tumor suppressor gene-2 (MTS2, CDKN1, p15INK4B) in childhood acute lymphoblastic leukemia. Iravani M; Dhat R; Price CM Oncogene; 1997 Nov; 15(21):2609-14. PubMed ID: 9399648 [TBL] [Abstract][Full Text] [Related]
39. Association of CDKN2A/p16INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Loughran O; Malliri A; Owens D; Gallimore PH; Stanley MA; Ozanne B; Frame MC; Parkinson EK Oncogene; 1996 Aug; 13(3):561-8. PubMed ID: 8760298 [TBL] [Abstract][Full Text] [Related]
40. Infrequent somatic mutations of the p16 and p15 genes in human bladder cancer: p16 mutations occur only in low-grade and superficial bladder cancers. Miyamoto H; Kubota Y; Fujinami K; Dobashi Y; Kondo K; Yao M; Shuin T; Hosaka M Oncol Res; 1995; 7(7-8):327-30. PubMed ID: 8747595 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]